
RadNet RDNT
€ 54.11
3.86%
Geschäftsbericht 2025
hinzugefügt 02.03.2026
RadNet P/B 2011-2026 | RDNT
P/B Jährlich RadNet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.15 | 3.25 | 2.96 | 2.66 | 4.57 | 3.86 | 7.45 | 5.04 | 7.77 | 5.63 | 8.04 | 60.4 | -930 | -44.1 | -1.29 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 60.4 | -930 | -57.3 |
P/B anderer Aktien in der Diagnostik & Forschung
| Name | P/B | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
1.47 | - | -6.23 % | $ 30.6 M | ||
|
ICON Public Limited Company
ICLR
|
1.74 | $ 98.33 | 0.9 % | $ 8.11 B | ||
|
Akumin
AKU
|
0.532 | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
6.75 | - | -6.19 % | $ 10.5 M | ||
|
Brainsway Ltd.
BWAY
|
3.17 | $ 13.71 | -0.22 % | $ 99.4 M | ||
|
Charles River Laboratories International
CRL
|
2.4 | $ 155.46 | 1.83 % | $ 7.71 B | ||
|
Bioventus
BVS
|
2.66 | $ 8.62 | 0.23 % | $ 574 M | ||
|
DexCom
DXCM
|
9.29 | $ 64.24 | -1.56 % | $ 25.1 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
1.97 | - | - | $ 562 M | ||
|
Castle Biosciences
CSTL
|
1.56 | $ 25.56 | 0.95 % | $ 710 M | ||
|
CareDx, Inc
CDNA
|
3.28 | $ 17.01 | 3.4 % | $ 906 M | ||
|
Accelerate Diagnostics
AXDX
|
-1.81 | - | -61.36 % | $ 2.46 M | ||
|
Exact Sciences Corporation
EXAS
|
8.12 | $ 103.57 | 0.29 % | $ 19.5 B | ||
|
Guardant Health
GH
|
-135 | $ 85.49 | 1.75 % | $ 10.7 B | ||
|
Global Cord Blood Corporation
CO
|
0.0498 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
3.46 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
561 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
1.28 | - | 0.12 % | $ 80.1 M | ||
|
Fulgent Genetics
FLGT
|
0.413 | $ 14.77 | 0.61 % | $ 447 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.32 | - | - | $ 10.7 B | ||
|
Biodesix
BDSX
|
4.41 | $ 17.88 | -6.63 % | $ 2.32 B | ||
|
Anixa Biosciences
ANIX
|
0.00742 | $ 2.83 | -1.05 % | $ 91.8 K | ||
|
Danaher Corporation
DHR
|
1.79 | $ 187.32 | 0.57 % | $ 134 B | ||
|
IQVIA Holdings
IQV
|
4.27 | $ 164.72 | 1.1 % | $ 28.3 B | ||
|
Biocept
BIOC
|
0.67 | - | -13.05 % | $ 7.29 M | ||
|
Heska Corporation
HSKA
|
2 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
0.554 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
2.6 | $ 118.94 | 2.92 % | $ 18.9 B | ||
|
Quest Diagnostics Incorporated
DGX
|
1.44 | $ 199.7 | -0.46 % | $ 22.2 B | ||
|
QIAGEN N.V.
QGEN
|
1.84 | - | - | $ 10.6 B | ||
|
Agilent Technologies
A
|
7.78 | $ 111.51 | -0.06 % | $ 33.9 B | ||
|
BioNano Genomics
BNGO
|
0.1 | $ 1.11 | -0.89 % | $ 1.41 M | ||
|
DarioHealth Corp.
DRIO
|
0.45 | $ 9.0 | -0.99 % | $ 255 M | ||
|
Neogen Corporation
NEOG
|
0.492 | $ 9.09 | -2.78 % | $ 1.97 B | ||
|
National Research Corporation
NRC
|
22.5 | $ 16.52 | 0.12 % | $ 370 M | ||
|
Chembio Diagnostics
CEMI
|
0.707 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-2.99 | - | - | $ 9.42 M | ||
|
Pacific Biosciences of California
PACB
|
93.1 | $ 1.33 | 4.72 % | $ 399 M | ||
|
Co-Diagnostics
CODX
|
0.406 | - | - | $ 79.8 M | ||
|
Medpace Holdings
MEDP
|
28.2 | $ 450.41 | 1.48 % | $ 13 B | ||
|
Celcuity
CELC
|
3.45 | $ 114.22 | 3.11 % | $ 4.51 B | ||
|
DermTech
DMTK
|
0.742 | - | -11.32 % | $ 2.94 M | ||
|
Mettler-Toledo International
MTD
|
-1.2 K | $ 1 173.74 | 0.49 % | $ 24.2 B | ||
|
Personalis
PSNL
|
1.25 | $ 6.72 | 1.97 % | $ 398 M | ||
|
NeoGenomics
NEO
|
1.77 | $ 7.88 | -1.25 % | $ 1.01 B | ||
|
Enzo Biochem
ENZ
|
0.00103 | - | -8.98 % | $ 14.8 K | ||
|
Natera
NTRA
|
7.52 | $ 187.85 | -1.29 % | $ 18.5 B | ||
|
Sotera Health Company
SHC
|
7.84 | $ 13.42 | 0.71 % | $ 3.81 B | ||
|
Invitae Corporation
NVTA
|
5.02 | - | - | $ 21.2 M | ||
|
OPKO Health
OPK
|
0.889 | $ 1.19 | 2.59 % | $ 826 M |